Under the deal – financial terms of which were not disclosed – eClinicalGPS, Greenphire’s site and vendor payment system, will be integrated into Merge’s electronic data capture (EDC) platform for clinical research applications.
The idea is that sponsors will be able to automate research site and clinical vendor payments in local currency through Greenphire's centralized web-based payment engine which – according to the firm – will reduce both setup times and the admin burden sites and sponsors face.
“Our alliance with Merge enables us to collaboratively bring an innovative and complementary set of technologies to the clinical research industry, driving additional efficiency to sponsors, CROs and sites on a global basis,” said Greenphire CEO Sam Whitaker.
“Our integrated functionality with Merge adds value to existing Merge and Greenphire clients, and offers operational efficiencies which our industry has never achieved previously."
Greenphire first hit the headlines last year when US drug giant Pfizer chose Clinicard as a central technology for its REMOTE ‘virtual clinical trial’ – which sought to eliminate clinic visits using mobile solutions capable of collecting data from patients in their own homes.
More recently – in October –Northern Ireland-based manufacturing and clinical services organisation Almac teamed up with Greenphire to combine its interactive voice and web response platform with Clincard – to create a service designed to encourage patient participation.